Atlas Trials

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17

Clinical trial NCT00897065 · UNKNOWN

Trial details

NCT number
NCT00897065
Sponsor
Massachusetts General Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2006-06-01
Enrollment
957

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.